Brazil health regulator approves clinical trials of Oxford COVID-19 vaccine

Brazil's health regulator Anvisa has approved human clinical trials for a potential coronavirus vaccine developed by scientists at Oxford University and supported by AstraZeneca Plc, it said on Wednesday.